Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17,270
Closed -$2.35M 372
2025
Q4
$2.35M Buy
17,270
+803
+5% +$115K 0.06% 130
2025
Q3
$2.43M Sell
16,467
-362
-2% -$50.2K 0.06% 125
2025
Q2
$2.18M Buy
16,829
+1
+0% +$121 0.05% 131
2025
Q1
$2.01M Sell
16,828
-280
-2% -$34.7K 0.06% 126
2024
Q4
$1.98M Buy
17,108
+286
+2% +$36.2K 0.05% 122
2024
Q3
$2.27M Buy
+16,822
New +$2.25M 0.06% 114
2024
Q1
Sell
-2,224
Closed -$254K 300
2023
Q4
$254K Buy
+2,224
New +$222K 0.01% 250

Other funds holding XYL

Chicago Capital's XYL Position: Q1 2026 in Review

Chicago Capital sold out of Xylem (XYL) in Q1 2026, closing a stake of 17,270 shares — an estimated $2.35M sold.

Chicago Capital first reported a position in XYL in Q4 2023 and held it in 7 quarters. The position peaked at $2.43M in Q3 2025. 1,108 funds tracked by Wall St. Rank hold XYL as of Q1 2026.

  • Chicago Capital reported no remaining Xylem position as of Q1 2026 after selling out during the quarter.
  • Chicago Capital sold 17,270 Xylem shares in Q1 2026, an estimated $2.35M.
  • Chicago Capital first reported a position in Xylem in Q4 2023 and held it in 7 quarters.
  • Chicago Capital's Xylem position peaked at $2.43M in Q3 2025.
  • 1,108 funds tracked by Wall St. Rank held Xylem as of Q1 2026.

Based on Chicago Capital's 13F filing for Q1 2026, filed 24 Apr 2026.